See All Resources

Response to the FDA’s RFI on Rare Disease Clinical Trial Networks, supporting the Rare Disease Cures Accelerator (Public Comments)

Comments provided on: July 20, 2020

Comments provided to: Food and Drug Administration (FDA)

Link to response